| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Group of Radiation Biology and Tumor Physiology, Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway
Requests for reprints: Einar K. Rofstad, Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway. Phone: 47-2293-4279; Fax: 47-2293-4270; E-mail: e.k.rofstad{at}labmed.uio.no.
Extracellular pH (pHe) is lower in many tumors than in the corresponding normal tissue. The significance of acidic pHe in the development of metastatic disease was investigated in the present work. Human melanoma cells (A-07, D-12, and T-22) were cultured in vitro at pHe 6.8 or 7.4 (control) before being inoculated into the tail vein of BALB/c nu/nu mice for formation of experimental pulmonary metastases. Cell invasiveness was studied in vitro by using Matrigel invasion chambers and angiogenesis was studied in vivo by using an intradermal assay. Protein secretion was measured by ELISA and immunocapture assays. Cells cultured at acidic pHe showed increased secretion of proteinases and proangiogenic factors, enhanced invasive and angiogenic potential, and enhanced potential to develop experimental metastases. Acidity-induced metastasis was inhibited by treatment with the general matrix metalloproteinase (MMP) inhibitor GM6001, the general cysteine proteinase inhibitor E-64, or blocking antibody against vascular endothelial growth factor-A (VEGF-A) or interleukin-8 (IL-8). Our study indicates that acidic pHe promotes experimental pulmonary metastasis in A-07, D-12, and T-22 human melanoma cells by a common mechanism involving acidity-induced up-regulation of the proteolytic enzymes MMP-2, MMP-9, cathepsin B, and cathepsin L and acidity-induced up-regulation of the proangiogenic factors VEGF-A and IL-8. One consequence of this observation is that treatment strategies involving deliberate tumor acidification to improve the efficacy of chemotherapy, photodynamic therapy, and hyperthermia should be avoided. Moreover, the possibility that the pHe of the primary tumor may be an important prognostic parameter for melanoma patients merits clinical investigation. (Cancer Res 2006; 66(13): 6699-707)
This article has been cited by other articles:
![]() |
M.-F. Penet, A. P. Pathak, V. Raman, P. Ballesteros, D. Artemov, and Z. M. Bhujwalla Noninvasive Multiparametric Imaging of Metastasis-Permissive Microenvironments in a Human Prostate Cancer Xenograft Cancer Res., November 15, 2009; 69(22): 8822 - 8829. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hersey, R. N. Watts, X. D. Zhang, and J. Hackett Metabolic Approaches to Treatment of Melanoma Clin. Cancer Res., November 1, 2009; 15(21): 6490 - 6494. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-Y. Juan, S. R. Roffler, H.-S. Hou, S.-M. Huang, K.-C. Chen, Y.-L. Leu, Z. M. Prijovich, C.-P. Yu, C.-C. Wu, G.-H. Sun, et al. Antiangiogenesis Targeting Tumor Microenvironment Synergizes Glucuronide Prodrug Antitumor Activity Clin. Cancer Res., July 15, 2009; 15(14): 4600 - 4611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. HARGUINDEY, J. L. ARRANZ, M. L. WAHL, G. ORIVE, and S. J. RESHKIN Proton Transport Inhibitors as Potentially Selective Anticancer Drugs Anticancer Res, June 1, 2009; 29(6): 2127 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Vavere, G. B. Biddlecombe, W. M. Spees, J. R. Garbow, D. Wijesinghe, O. A. Andreev, D. M. Engelman, Y. K. Reshetnyak, and J. S. Lewis A Novel Technology for the Imaging of Acidic Prostate Tumors by Positron Emission Tomography Cancer Res., May 15, 2009; 69(10): 4510 - 4516. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gillet, S. Roger, P. Besson, F. Lecaille, J. Gore, P. Bougnoux, G. Lalmanach, and J.-Y. Le Guennec Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells J. Biol. Chem., March 27, 2009; 284(13): 8680 - 8691. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Robey, B. K. Baggett, N. D. Kirkpatrick, D. J. Roe, J. Dosescu, B. F. Sloane, A. I. Hashim, D. L. Morse, N. Raghunand, R. A. Gatenby, et al. Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases Cancer Res., March 15, 2009; 69(6): 2260 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Silva, J. A. Yunes, R. J. Gillies, and R. A. Gatenby The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion Cancer Res., March 15, 2009; 69(6): 2677 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chiche, K. Ilc, J. Laferriere, E. Trottier, F. Dayan, N. M. Mazure, M. C. Brahimi-Horn, and J. Pouyssegur Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH Cancer Res., January 1, 2009; 69(1): 358 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tu, C. F. Ortega-Cava, G. Chen, N. D. Fernandes, D. Cavallo-Medved, B. F. Sloane, V. Band, and H. Band Lysosomal Cathepsin B Participates in the Podosome-Mediated Extracellular Matrix Degradation and Invasion via Secreted Lysosomes in v-Src Fibroblasts Cancer Res., November 15, 2008; 68(22): 9147 - 9156. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gillies, I. Robey, and R. A. Gatenby Causes and Consequences of Increased Glucose Metabolism of Cancers J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kassie, L. B. Anderson, L. Higgins, Y. Pan, I. Matise, M. Negia, P. Upadhyaya, M. Wang, and S. S. Hecht Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice Carcinogenesis, March 1, 2008; 29(3): 610 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Supino, G. Petrangolini, G. Pratesi, M. Tortoreto, E. Favini, L. D. Bo, P. Casalini, E. Radaelli, A. C. Croce, G. Bottiroli, et al. Antimetastatic Effect of a Small-Molecule Vacuolar H+-ATPase Inhibitor in in Vitro and in Vivo Preclinical Studies J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stuwe, M. Muller, A. Fabian, J. Waning, S. Mally, J. Noel, A. Schwab, and C. Stock pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution J. Physiol., December 1, 2007; 585(2): 351 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fais, A. De Milito, H. You, and W. Qin Targeting Vacuolar H+-ATPases as a New Strategy against Cancer Cancer Res., November 15, 2007; 67(22): 10627 - 10630. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Provent, M. Benito, B. Hiba, R. Farion, P. Lopez-Larrubia, P. Ballesteros, C. Remy, C. Segebarth, S. Cerdan, J. A. Coles, et al. Serial In vivo Spectroscopic Nuclear Magnetic Resonance Imaging of Lactate and Extracellular pH in Rat Gliomas Shows Redistribution of Protons Away from Sites of Glycolysis Cancer Res., August 15, 2007; 67(16): 7638 - 7645. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Senan and E. F. Smit Design of Clinical Trials of Radiation Combined with Antiangiogenic Therapy Oncologist, April 1, 2007; 12(4): 465 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Gorodeski Estrogen Decrease in Tight Junctional Resistance Involves Matrix-Metalloproteinase-7-Mediated Remodeling of Occludin Endocrinology, January 1, 2007; 148(1): 218 - 231. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |